Nature's Sunshine Products, Inc.

Good afternoon, everyone, and thank you for participating in today's conference call to discuss Nature Sunshine financial results for the fourth quarter and full year ended December 31, 2025. Joining us today are Nature Sunshine CEO Ken Romanci, CFO Shane Jones, and General Counsel Nate Brower. Following their remarks, we'll open the call for analyst questions. Before we go further, I would like to turn the call over to Mr. Brower, as she reads the company's safe harbor statement reading the meaning of the Private Securities Litigation Reform Act of 1995 that provides important cautions regarding forward-looking statements. Nate, please go ahead.

Hey, thank you. Good afternoon, and thanks for joining our conference call to discuss our fourth quarter and full year 2025 financial results. I'd like to remind everyone that this call is available for replay by telephonic dial-in through March 24th, and by a live webcast that will be posted on the investor relations portion of our website at ir.naturesunshine.com. The information on this call contains forward-looking statements. These statements are often characterized by terminologies such as believe, hope, may, anticipate, expect, will, and other similar expressions. Forward-looking statements are not guarantees of future performance, and the actual results may be materially different from the results implied by forward-looking statements. Factors that could cause results to differ materially from those implied herein include, but are not limited to, those factors disclosed in the company's annual report on Form 10-K under the caption risk factors, and other reports filed with the Securities and Exchange Commission. The information on this call speaks only as of today's date, and the company disclaims any duty to update the information provided herein. Now, I would like to turn the call over to the CEO of Nature Sunshine, Ken Romanti. Ken?

Thank you, Nate, and good afternoon, everyone. Thank you for joining our fourth quarter and full year 2025 earnings call. I've now been at Nature Sunshine for 131 days, and I am even more delighted to be here than when I last spoke to you on our third quarter earnings call on November 6th of last year. Nature Sunshine delivered another terrific quarter, growing sales 5% and EBITDA 10% by continuing to execute against its key drivers of success, leading to its highest annual sales level ever. But I'm most pleased by what I have found in this great company over the past three months. Simply put, I love what I see. Two very strong brands steeped in heritage and quality, Nature Sunshine and Synergy, operating in the large global and rapidly growing category of natural health supplements. A globally diverse business operating in over 40 countries around the world. Exceptional product development capabilities sourcing and blending hundreds of nature's best ingredients from around the world and scientifically verifying their effectiveness. An army of independent consultants passionately representing our products every day to consumers all over the world. A rapidly growing digital business penetrating new channels driven by a subscription strategy that enables consistent recurring revenue streams. A rock solid balance sheet with nearly $100 million in cash and no debt. And last but not least, a passionate mission driven organization dedicated to elevating people's lives globally through improving their health and economic well-being, while delivering industry-leading results for our shareholders. Suffice to say, I see so much to build upon at Nature Sunshine, and I believe we can drive even more accelerated growth going forward. I will share an outline for the future of Nature Sunshine after our CFO, Shane Jones, provides the details of our strong fourth quarter performance. Shane?